U.S. Drug Spending Climbs

An IMS Health report says total spending on prescription drugs in the U.S. rose 12.2% to nearly $425 billion in 2015. They say the rise is part of a continuing steep climb fueled by the introduction in recent years of expensive drugs for cancer and infections, as well as price hikes for older drugs. The Pharmaceutical Research and Manufacturers of America says the report confirms that drug costs are moderating due to a competitive marketplace for medicines where large, powerful purchasers negotiate aggressively and generic utilization rates are nearly 90%.

 

To find out more on this topic, please read the article titled, "U.S. Drug Spending Climbs" courtesy of The Wall Street Journal.

Related News:
U.S. prescription drug spending to hit $400 billion a year by 2020: IMS – Reuters

HORIZON Health Ventures is a healthcare cost management solutions company used by insurance brokers, employee benefit consultants, third-party administrators, insurance companies, and associations, to bring proven thought leadership and strategy to the management of their clients healthcare costs. To learn more about HHV and their services, please visit http://horizonhealthventures.com/